Microfluidics Market By Application (Medical/Healthcare, Non-Medical) , By Material (Silicone, Glass, Polymer, PDMS, Others) By Technology (Lab-On-A-Chip, Organs-On-Chips, Continuous Flow Microfluidics, Optofluidics & Microfluidics, Acoustofluidics & Microfluidics, Electrophoresis & Microfluidics) : Global Opportunity Analysis and Industry Forecast, 2024-2033

August 2024 | 320 pages | ID: M6F2D65DF183EN
Allied Market Research

Abstracts

Microfluidics Market Expected to Garner $77.5 Billion by 2033, Growing at a CAGR of 13.7%

Abstract: The global microfluidics market is expected to grow primarily due to the growing demand for point-of-care diagnostics and adoption in biomedical research, diagnostics, & drug delivery. The Asia-Pacific region is predicted to witness profitable growth by 2033.

As per the report published by Research Dive, the global microfluidics market was valued at $23.2 billion in 2023 and is expected to register a revenue of $77.5 billion by 2033 at a CAGR of 13.7% during the forecast period 2024-2033.

Dynamics of the Market

The increasing need for point of care diagnostics and the rising adoption in biomedical research, diagnostics, & drug delivery are expected to make the microfluidics market a highly profitable one in the forecast period. Besides, the growth in the wearable device industry is expected to drive market growth.

However, according to market analysts, the stringent regulatory requirements and the high initial costs associated with microfluidic devices might restrain the growth of the market.

Advanced technologies for microfluidic system design & manufacturing and the development of new products & device miniaturization are predicted to offer numerous growth opportunities for the microfluidics market in the forecast period. Moreover, the growing utilization of 3D printing technologies for rapid prototyping & customization of microfluidic devices is expected to boost the market forward in the coming years.

Key Players of the Market

The major players of the microfluidics market include Illumina, Inc., F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., PerkinElmer, Inc., Agilent Technologies, Inc., Thermo Fisher Scientific, Standard BioTools, Abbott, and Danaher Corporation.

What the Report Covers

In addition to the details highlighted in this description, the comprehensive final report delves into essential market aspects. These encompass a market overview, SWOT analysis, market dynamics, Porter’s five forces analysis, segmentation (key trends, regional analysis, and forecast analysis), and company profiles (including company overview, product portfolio, operating segments, strategic initiatives, and financial performance).

Additional benefits you will get with this purchase are:

• Quarterly Update and* (only available with a corporate license, on listed price)
• 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
• Free Upcoming Version on the Purchase of Five and Enterprise User License.
• 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
• 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
• Free data Pack on the Five and Enterprise User License. (Excel version of the report)
• Free Updated report if the report is 6-12 months old or older.
• 24-hour priority response*
• Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

• Product Benchmarking / Product specification and applications
• Technology Trend Analysis
• Market share analysis of players by products/segments
• New Product Development/ Product Matrix of Key Players
• Patient/epidemiology data at country, region, global level
• Regulatory Guidelines
• Additional company profiles with specific to client's interest
• Additional country or region analysis- market size and forecast
• Criss-cross segment analysis- market size and forecast
• Historic market data
• Key player details (including location, contact details, supplier/vendor network etc. in excel format)
• List of customers/consumers/raw material suppliers- value chain analysis
• Market share analysis of players at global/region/country level
• SWOT Analysis

Key Market Segments

By Application

• Medical/Healthcare
• Non-Medical

By Material

• Silicone
• Glass
• Polymer
• PDMS
• Others

By Technology

• Lab-On-A-Chip
• Organs-On-Chips
• Continuous Flow Microfluidics
• Optofluidics Microfluidics
• Acoustofluidics Microfluidics
• Electrophoresis Microfluidics

By Region

• North America
• U.S.
• Canada
• Mexico
• Europe
• France
• Germany
• Italy
• Spain
• UK
• Rest of Europe
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Rest of Asia-Pacific
• LAMEA
• Brazil
• South Africa
• Saudi Arabia
• UAE
• Rest of LAMEA
• Key Market Players
• Illumina, Inc.
• Bio-Rad Laboratories, Inc.
• F. Hoffmann-La Roche Ltd
• PerkinElmer, Inc.
• Thermo Fisher Scientific Inc.
• Agilent Technologies, Inc.
• Standard BioTools
• Danaher Corporation
• Abbott
• bioMerieux

Contents

CHAPTER 1: INTRODUCTION

1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
  1.4.1. Primary Research
  1.4.2. Secondary Research
  1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

3.1. Market Definition and Scope
3.2. Key Findings
  3.2.1. Top Investment Pockets
  3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
  3.3.1. Bargaining Power of Suppliers
  3.3.2. Threat of New Entrants
  3.3.3. Threat of Substitutes
  3.3.4. Competitive Rivalry
  3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
  3.4.1. Drivers
  3.4.2. Restraints
  3.4.3. Opportunities

CHAPTER 4: MICROFLUIDICS MARKET, BY APPLICATION

4.1. Market Overview
  4.1.1 Market Size and Forecast, By Application
4.2. Medical/Healthcare
  4.2.1. Key Market Trends, Growth Factors and Opportunities
  4.2.2. Market Size and Forecast, By Region
  4.2.3. Market Share Analysis, By Country
4.3. Non-Medical
  4.3.1. Key Market Trends, Growth Factors and Opportunities
  4.3.2. Market Size and Forecast, By Region
  4.3.3. Market Share Analysis, By Country

CHAPTER 5: MICROFLUIDICS MARKET, BY MATERIAL

5.1. Market Overview
  5.1.1 Market Size and Forecast, By Material
5.2. Silicone
  5.2.1. Key Market Trends, Growth Factors and Opportunities
  5.2.2. Market Size and Forecast, By Region
  5.2.3. Market Share Analysis, By Country
5.3. Glass
  5.3.1. Key Market Trends, Growth Factors and Opportunities
  5.3.2. Market Size and Forecast, By Region
  5.3.3. Market Share Analysis, By Country
5.4. Polymer
  5.4.1. Key Market Trends, Growth Factors and Opportunities
  5.4.2. Market Size and Forecast, By Region
  5.4.3. Market Share Analysis, By Country
5.5. PDMS
  5.5.1. Key Market Trends, Growth Factors and Opportunities
  5.5.2. Market Size and Forecast, By Region
  5.5.3. Market Share Analysis, By Country
5.6. Others
  5.6.1. Key Market Trends, Growth Factors and Opportunities
  5.6.2. Market Size and Forecast, By Region
  5.6.3. Market Share Analysis, By Country

CHAPTER 6: MICROFLUIDICS MARKET, BY TECHNOLOGY

6.1. Market Overview
  6.1.1 Market Size and Forecast, By Technology
6.2. Lab-On-A-Chip
  6.2.1. Key Market Trends, Growth Factors and Opportunities
  6.2.2. Market Size and Forecast, By Region
  6.2.3. Market Share Analysis, By Country
6.3. Organs-On-Chips
  6.3.1. Key Market Trends, Growth Factors and Opportunities
  6.3.2. Market Size and Forecast, By Region
  6.3.3. Market Share Analysis, By Country
6.4. Continuous Flow Microfluidics
  6.4.1. Key Market Trends, Growth Factors and Opportunities
  6.4.2. Market Size and Forecast, By Region
  6.4.3. Market Share Analysis, By Country
6.5. Optofluidics Microfluidics
  6.5.1. Key Market Trends, Growth Factors and Opportunities
  6.5.2. Market Size and Forecast, By Region
  6.5.3. Market Share Analysis, By Country
6.6. Acoustofluidics Microfluidics
  6.6.1. Key Market Trends, Growth Factors and Opportunities
  6.6.2. Market Size and Forecast, By Region
  6.6.3. Market Share Analysis, By Country
6.7. Electrophoresis Microfluidics
  6.7.1. Key Market Trends, Growth Factors and Opportunities
  6.7.2. Market Size and Forecast, By Region
  6.7.3. Market Share Analysis, By Country

CHAPTER 7: MICROFLUIDICS MARKET, BY REGION

7.1. Market Overview
  7.1.1 Market Size and Forecast, By Region
7.2. North America
  7.2.1. Key Market Trends and Opportunities
  7.2.2. Market Size and Forecast, By Application
  7.2.3. Market Size and Forecast, By Material
  7.2.4. Market Size and Forecast, By Technology
  7.2.5. Market Size and Forecast, By Country
  7.2.6. U.S. Microfluidics Market
    7.2.6.1. Market Size and Forecast, By Application
    7.2.6.2. Market Size and Forecast, By Material
    7.2.6.3. Market Size and Forecast, By Technology
  7.2.7. Canada Microfluidics Market
    7.2.7.1. Market Size and Forecast, By Application
    7.2.7.2. Market Size and Forecast, By Material
    7.2.7.3. Market Size and Forecast, By Technology
  7.2.8. Mexico Microfluidics Market
    7.2.8.1. Market Size and Forecast, By Application
    7.2.8.2. Market Size and Forecast, By Material
    7.2.8.3. Market Size and Forecast, By Technology
7.3. Europe
  7.3.1. Key Market Trends and Opportunities
  7.3.2. Market Size and Forecast, By Application
  7.3.3. Market Size and Forecast, By Material
  7.3.4. Market Size and Forecast, By Technology
  7.3.5. Market Size and Forecast, By Country
  7.3.6. France Microfluidics Market
    7.3.6.1. Market Size and Forecast, By Application
    7.3.6.2. Market Size and Forecast, By Material
    7.3.6.3. Market Size and Forecast, By Technology
  7.3.7. Germany Microfluidics Market
    7.3.7.1. Market Size and Forecast, By Application
    7.3.7.2. Market Size and Forecast, By Material
    7.3.7.3. Market Size and Forecast, By Technology
  7.3.8. Italy Microfluidics Market
    7.3.8.1. Market Size and Forecast, By Application
    7.3.8.2. Market Size and Forecast, By Material
    7.3.8.3. Market Size and Forecast, By Technology
  7.3.9. Spain Microfluidics Market
    7.3.9.1. Market Size and Forecast, By Application
    7.3.9.2. Market Size and Forecast, By Material
    7.3.9.3. Market Size and Forecast, By Technology
  7.3.10. UK Microfluidics Market
    7.3.10.1. Market Size and Forecast, By Application
    7.3.10.2. Market Size and Forecast, By Material
    7.3.10.3. Market Size and Forecast, By Technology
  7.3.11. Rest Of Europe Microfluidics Market
    7.3.11.1. Market Size and Forecast, By Application
    7.3.11.2. Market Size and Forecast, By Material
    7.3.11.3. Market Size and Forecast, By Technology
7.4. Asia-Pacific
  7.4.1. Key Market Trends and Opportunities
  7.4.2. Market Size and Forecast, By Application
  7.4.3. Market Size and Forecast, By Material
  7.4.4. Market Size and Forecast, By Technology
  7.4.5. Market Size and Forecast, By Country
  7.4.6. China Microfluidics Market
    7.4.6.1. Market Size and Forecast, By Application
    7.4.6.2. Market Size and Forecast, By Material
    7.4.6.3. Market Size and Forecast, By Technology
  7.4.7. Japan Microfluidics Market
    7.4.7.1. Market Size and Forecast, By Application
    7.4.7.2. Market Size and Forecast, By Material
    7.4.7.3. Market Size and Forecast, By Technology
  7.4.8. India Microfluidics Market
    7.4.8.1. Market Size and Forecast, By Application
    7.4.8.2. Market Size and Forecast, By Material
    7.4.8.3. Market Size and Forecast, By Technology
  7.4.9. South Korea Microfluidics Market
    7.4.9.1. Market Size and Forecast, By Application
    7.4.9.2. Market Size and Forecast, By Material
    7.4.9.3. Market Size and Forecast, By Technology
  7.4.10. Australia Microfluidics Market
    7.4.10.1. Market Size and Forecast, By Application
    7.4.10.2. Market Size and Forecast, By Material
    7.4.10.3. Market Size and Forecast, By Technology
  7.4.11. Rest of Asia-Pacific Microfluidics Market
    7.4.11.1. Market Size and Forecast, By Application
    7.4.11.2. Market Size and Forecast, By Material
    7.4.11.3. Market Size and Forecast, By Technology
7.5. LAMEA
  7.5.1. Key Market Trends and Opportunities
  7.5.2. Market Size and Forecast, By Application
  7.5.3. Market Size and Forecast, By Material
  7.5.4. Market Size and Forecast, By Technology
  7.5.5. Market Size and Forecast, By Country
  7.5.6. Brazil Microfluidics Market
    7.5.6.1. Market Size and Forecast, By Application
    7.5.6.2. Market Size and Forecast, By Material
    7.5.6.3. Market Size and Forecast, By Technology
  7.5.7. South Africa Microfluidics Market
    7.5.7.1. Market Size and Forecast, By Application
    7.5.7.2. Market Size and Forecast, By Material
    7.5.7.3. Market Size and Forecast, By Technology
  7.5.8. Saudi Arabia Microfluidics Market
    7.5.8.1. Market Size and Forecast, By Application
    7.5.8.2. Market Size and Forecast, By Material
    7.5.8.3. Market Size and Forecast, By Technology
  7.5.9. UAE Microfluidics Market
    7.5.9.1. Market Size and Forecast, By Application
    7.5.9.2. Market Size and Forecast, By Material
    7.5.9.3. Market Size and Forecast, By Technology
  7.5.10. Rest of LAMEA Microfluidics Market
    7.5.10.1. Market Size and Forecast, By Application
    7.5.10.2. Market Size and Forecast, By Material
    7.5.10.3. Market Size and Forecast, By Technology

CHAPTER 8: COMPETITIVE LANDSCAPE

8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping Of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

9.1. Illumina, Inc.
  9.1.1. Company Overview
  9.1.2. Key Executives
  9.1.3. Company Snapshot
  9.1.4. Operating Business Segments
  9.1.5. Product Portfolio
  9.1.6. Business Performance
  9.1.7. Key Strategic Moves and Developments
9.2. Bio-Rad Laboratories, Inc.
  9.2.1. Company Overview
  9.2.2. Key Executives
  9.2.3. Company Snapshot
  9.2.4. Operating Business Segments
  9.2.5. Product Portfolio
  9.2.6. Business Performance
  9.2.7. Key Strategic Moves and Developments
9.3. F. Hoffmann-La Roche Ltd
  9.3.1. Company Overview
  9.3.2. Key Executives
  9.3.3. Company Snapshot
  9.3.4. Operating Business Segments
  9.3.5. Product Portfolio
  9.3.6. Business Performance
  9.3.7. Key Strategic Moves and Developments
9.4. PerkinElmer, Inc.
  9.4.1. Company Overview
  9.4.2. Key Executives
  9.4.3. Company Snapshot
  9.4.4. Operating Business Segments
  9.4.5. Product Portfolio
  9.4.6. Business Performance
  9.4.7. Key Strategic Moves and Developments
9.5. Thermo Fisher Scientific Inc.
  9.5.1. Company Overview
  9.5.2. Key Executives
  9.5.3. Company Snapshot
  9.5.4. Operating Business Segments
  9.5.5. Product Portfolio
  9.5.6. Business Performance
  9.5.7. Key Strategic Moves and Developments
9.6. Agilent Technologies, Inc.
  9.6.1. Company Overview
  9.6.2. Key Executives
  9.6.3. Company Snapshot
  9.6.4. Operating Business Segments
  9.6.5. Product Portfolio
  9.6.6. Business Performance
  9.6.7. Key Strategic Moves and Developments
9.7. Standard BioTools
  9.7.1. Company Overview
  9.7.2. Key Executives
  9.7.3. Company Snapshot
  9.7.4. Operating Business Segments
  9.7.5. Product Portfolio
  9.7.6. Business Performance
  9.7.7. Key Strategic Moves and Developments
9.8. Danaher Corporation
  9.8.1. Company Overview
  9.8.2. Key Executives
  9.8.3. Company Snapshot
  9.8.4. Operating Business Segments
  9.8.5. Product Portfolio
  9.8.6. Business Performance
  9.8.7. Key Strategic Moves and Developments
9.9. Abbott
  9.9.1. Company Overview
  9.9.2. Key Executives
  9.9.3. Company Snapshot
  9.9.4. Operating Business Segments
  9.9.5. Product Portfolio
  9.9.6. Business Performance
  9.9.7. Key Strategic Moves and Developments
9.10. BioMerieux
  9.10.1. Company Overview
  9.10.2. Key Executives
  9.10.3. Company Snapshot
  9.10.4. Operating Business Segments
  9.10.5. Product Portfolio
  9.10.6. Business Performance
  9.10.7. Key Strategic Moves and Developments